Document ID: chunk:federal_register_of_legislation:F2024C00213:front:0:p3
Version: federal_register_of_legislation:F2024C00213
Segment Type: other
Provision Reference: 
Character Range: 5679–8691

in the Schedule 1 - Dictionary.
(2)          inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD):
(a)          for a cumulative period of at least 1,000 hours, within a consecutive period of 10 years before the clinical onset of myeloma; and
(b)          where the first exposure occurred at least 5 years before the clinical onset of myeloma;
            Note: inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) is defined in the Schedule 1 - Dictionary.
(3)          being:
(a)          on land in Vietnam; or
(b)          at sea in Vietnamese waters; or
(c)          on board a vessel and consuming potable water supplied on that vessel, when the water supply had been produced by evaporative distillation of estuarine Vietnamese waters;
         for a cumulative period of at least 30 days, at least 5 years before the clinical onset of myeloma;
            Note: being:
            (a) on land in Vietnam; or
            (b) at sea in Vietnamese waters, estuarine Vietnamese waters and potable water are defined in the Schedule 1 - Dictionary.
(4)          having infection with human immunodeficiency virus at the time of the clinical onset of myeloma;
(5)          undergoing organ or tissue transplantation, excluding corneal transplant and autologous stem cell transplantation, before the clinical onset of myeloma;
Note: organ or tissue transplantation is defined in the Schedule 1 - Dictionary.
(6)          being exposed to benzene as specified:
(a)          for a cumulative total of at least 2,500 hours within a continuous period of 5 years before the clinical onset of myeloma; and
(b)          where the first exposure in that period occurred at least 5 years before the clinical onset of myeloma;
Note: being exposed to benzene as specified is defined in the Schedule 1 - Dictionary.
(7)          receiving greater than 10 ppm-years of cumulative exposure to benzene before the clinical onset of myeloma, and where the first exposure occurred at least 5 years before the clinical onset of myeloma;
Note: ppm-years is defined in the Schedule 1 - Dictionary.
(8)          being overweight or obese for a continuous period of at least 5 years before the clinical onset of myeloma;
Note: being overweight or obese is defined in the Schedule 1 - Dictionary.
(9)          having an autoimmune disease from the specified list of autoimmune diseases at least 5 years before the clinical onset of myeloma;
Note: specified list of autoimmune diseases is defined in the Schedule 1 - Dictionary.
(10)      inability to obtain appropriate clinical management for myeloma.
     10           Relationship to service
(1)          The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.
(2)          The factor set out in subsection 9(10) applies only to material contribution